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Predictors of Hospitalization and Quality of Life in Heart Failure: A Model of
Comorbidity, Self-Efficacy and Self-Care
Abstract
Background
Comorbidity is associated with decreased confidence or self-efficacy to perform self-care in heart failure
patients which, in turn, impairs self-care behaviors. Comorbidity is also associated with increased
hospitalization rates and poorer quality of life. Yet the manner in which comorbidity and self-efficacy
interact to influence self-care, hospitalization, and quality of life remains unclear.
Objectives
The purpose of this study was to test an explanatory model. The research questions were (1) What is the
contribution of comorbidity to heart failure self-care behaviors and outcomes (i.e. hospitalization, quality
of life)? and (2) Is comorbidity a moderator of the relationship between self-efficacy and heart failure selfcare behaviors?
Design
This was an analysis of an existing dataset of 628 symptomatic, older (mean age = 73, standard deviation
(SD) = 11) male (58%) Italian heart failure patients using structural equation modeling and simple slope
analysis.
Results
Higher levels of self-care maintenance were associated with higher quality of life and lower
hospitalization rates. Higher levels of comorbidity were associated with lower levels of self-care
management. Comorbidity moderated the relationship between self-efficacy and self-care maintenance,
but not self-care management. Post hoc simple slopes analysis showed significantly different slope
coefficients (pdiff < .05). Specifically, in patients with less comorbidity, the relationship between selfefficacy and self-care was significantly stronger than in patients with higher comorbidity.
Conclusions
Self-efficacy is important in the self-care maintenance process at each level of comorbidity. Because
higher comorbidity weakens the strength of the relationship between self-efficacy and self-care
maintenance, tailoring interventions aimed at improving self-efficacy to different levels of comorbidity
may be key to impacting hospitalization and quality of life.
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Abstract
Background: Comorbidity is associated with deceased confidence or self-efficacy to
perform self-care in heart failure patients which, in turn, impairs self-care behaviors. Comorbidity is
also associated with increased hospitalization rates and poorer quality of life. Yet the manner in
which comorbidity and self-efficacy interact to influence self-care, hospitalization and quality of
life remains unclear.
Objectives: The purpose of this study was to test an explanatory model. The research
questions were: 1) What is the contribution of comorbidity to heart failure self-care behaviors and
outcomes (i.e. hospitalization, quality of life)? and 2) Is comorbidity a moderator of the relationship
between self-efficacy and heart failure self-care behaviors?
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Design: This was an analysis of an existing dataset of 628 symptomatic, older (mean age =
73, SD = 11) male (58%) Italian heart failure patients using structural equation modeling and
simple slope analysis.
Results: Higher levels of self-care maintenance were associated with higher quality of life
and lower hospitalization rates. Higher levels of comorbidity were associated with lower levels of
self-care management. Comorbidity moderated the relationship between self-efficacy and self-care
maintenance, but not self-care management. Post-hoc simple slopes analysis showed significantly
different slope coefficients (pdiff <.05). Specifically, in patients with less comorbidity, the
relationship between self-efficacy and self-care was significantly stronger than in patients with
higher comorbidity.
Conclusions: Self-efficacy is important in the self-care maintenance process at each level of
comorbidity. Because higher comorbidity weakens the strength of the relationship between selfefficacy and self-care maintenance, tailoring interventions aimed at improving self-efficacy to
different levels of comorbidity may be key to impacting hospitalization and quality of life.
Keywords: comorbidity, self-efficacy, self-care, explanatory model
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Introduction
Comorbidity, defined as two or more chronic conditions, is associated with longer lengths
of hospital stay, more hospital stays per year, and higher overall costs of care.(1, 2) In Italy, where
this study was conducted, approximately 50% of the general population between the ages of 65-74
has at least two chronic conditions.(3) This number jumps to 68% in heart failure populations (4)
with hospitalization accounting for 53% of the average costs.(5) It has been estimated that
comorbidity is responsible for 70-80% of heath care costs in Europe or approximately 700 billion
Euros in 2013.(2) In comorbid heart failure populations the need for concurrent adherence to
multiple self-care regimens and management of overlapping symptom profiles is common.(6)
Failures in self-care result in health system utilization and increased health care costs.(7)
Heart failure self-care is a 2 stage process.(8) First, self-care maintenance captures the day
to day treatment adherence and monitoring behaviors. Then self-care management includes
recognition of a change in homeostasis and response mobilization. The self-care process is
influenced by self-efficacy.(8, 9) Heart failure patients derive event-free survival benefits from
above average self-care and decreased hospitalization rates and improved quality of life from
adequate self-care (10-12) suggesting that the cost of heart failure may be mitigated by improving
self-care.
However, recent attempts to decrease hospitalizations using self-care interventions have
resulted in mixed outcomes.(13-16) In two, single site small RCTs, an in-person self-care
intervention did not change readmission rates in the first study (15) and in the second, a technology
intervention reduced 90 day hospital readmissions.(14) In a larger, multi-site three-arm RCT testing
the impact of stepped self-care interventions on readmission, no significant differences were found
when either intervention arm was compared with usual care.(13) Furthermore, a large meta-analysis
of heart failure education and monitoring studies conducted in 10 countries found significant
improvement in hospitalizations in 30 studies but also found a bias towards positive outcomes. (16)
One possible explanation for this outcome heterogeneity may be the role of comorbidity in the
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study. In each of these studies comorbidity functioned, if measured, as a sample descriptor rather
than an independent variable in multivariate analysis. So it is unclear what part, if any, comorbidity
may have played in the response to the interventions. Our study seeks to clarify this important point.
In earlier work we established that there is interaction between comorbidity, self-efficacy
and heart failure self-care in smaller samples.(6, 17) Specifically, we found that comorbidity
decreases self-efficacy. Self-efficacy, in turn, decreases self-care behaviors. Yet the manner in
which comorbidity and self-efficacy interact to influence self-care remains unclear. Building on this
earlier work, our goal in this study was to create an explanatory model for the manner in which
comorbidity, self-efficacy and heart failure self-care interact and test it structurally with meaningful
outcomes – hospitalization and quality of life.
Therefore, the specific aim of this study was to test an explanatory model of known
predictors of hospitalization and quality of life. The research questions were: 1) What is the
contribution of comorbidity to heart failure self-care behaviors and outcomes (i.e. hospitalization,
quality of life) adjusting for age and gender? and 2) Is comorbidity a moderator of the relationship
between self-efficacy and heart failure self-care behaviors? Knowing the interaction among selfefficacy, comorbidity and self-care would clarify the mechanism by which hospitalization and
quality of life are affected. This is important as self-efficacy is potentially modifiable and
interventions designed to improve self-efficacy may differ when patients have different levels of
comorbidity.
Methods
Study design and setting
This was a secondary analysis of a large cross-sectional database that described self-care in
Italian heart failure patients.(18) In the parent study, a convenience sample of 1,192 adults with
heart failure was enrolled from cardiovascular centres located across 28 provinces in northern,
central, and southern Italy. Data were collected between January 2011 and November 2012.
Sample
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The inclusion criteria parent study were: 1) adults over age 18; 2) diagnosis of heart failure
by a cardiologist, confirmed by echocardiogram and clinical evidence of heart failure (e.g. typical
signs and symptoms of heart failure such as edema or elevated jugular venous pressure and
dyspnea) as specified in the diagnostic criteria of the European Society of Cardiology.(19)
Individuals were excluded if they had experienced an acute coronary event in the prior three months
or had a diagnosis of dementia.
For this analysis we selected only those heart failure patients who had experienced
symptoms in the prior month (n=628) to allow us to analyze symptom management behaviors.
While power analysis for structural equation modeling is difficult (20), using traditional power
analysis software for 3 predictors where the squared multiple correlation is .25 and detection of a
predictor that accounts for at least 5% unique variance in the outcome variable is desired; the
required sample size to achieve .90 power is approximately 215, signifying that we had a sufficient
sample size to conduct this analysis.
Ethical consideration
The investigation confirmed to the principles outlined in the Declaration of Helsinki
obtaining ethical review of all procedures prior to data collection in each center where patients were
enrolled.
Data Collection
Data collectors were nurses who received at least 4 hours of training by the principal
investigator on the study protocol. Training included: patient selection using inclusion/exclusion
criteria, informed consent, instrument administration, and medical record abstraction for
hospitalization data. Data were regularly monitored by the principal investigator for protocol
adherence. Sociodemographic data (age, gender, education, marital status, job, family income), used
to describe the sample, were collected using an investigator-developed survey instrument.
Measures
Comorbidity
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Comorbidity was measured using the revised, 12 item Charlson Comorbidity Index
(CCI).(21) Each item has a possible score of 1, 2, 3 or 6. Heart failure is scored a 2 in this new
version. Higher scores indicate higher comorbidity. The CCI is widely used in Italian studies with
heart failure patients.(22, 23) Psychometric testing comparing the predictive ability of the revised
vs. the gold standard original CCI found that it was comparable (C statistic range .73-.88). The CCI
was completed by trained nursing research assistants abstracting information from patients’ medical
records.
Self-Efficacy
Self-efficacy was measured using the self-care confidence scale of the Self-Care of Heart
Failure Index (SCHFI V6.2).(24) The self-care confidence scale measures self-efficacy according to
Bandura’s conceptualization (25) that is, self-care confidence scale items describe capability and
the scaling (1-4) provides the strength of the belief. Each of the 6 items asks about confidence in
their ability to perform specific self-care maintenance and management behaviors (e.g., follow
treatment regimen, manage symptoms). Measured on a four-point Likert scale, responses are
summed and standardized to 0 - 100; higher scores indicate higher self-efficacy. Psychometric
testing found that this scale is valid and reliable in the Italian population.(26) Specifically,
confirmatory factor analysis showed a comparative fit index of 0.99, and a root mean square error
of approximation of 0.02. Reliability tested with factor score determinacy, a more appropriate
reliability testing for the SCHFI dimensionality,(27, 28) resulted with a coefficient of 0.82.(26)
Self-care confidence is hereafter referred to as self-efficacy.(6)
Self-Care Maintenance and Self-Care Management
Heart failure self-care was measured using the SCHFI V6.2. The SCHFI is a well validated
instrument that measures self-care maintenance (adherence to treatment regimens and symptom
monitoring behaviors) with 10 items and self-care management (ability to recognize and respond
appropriately to symptoms) with 6 items on a four-point Likert scale. Scores on the maintenance
and management scales are standardized to 0 – 100 score; higher scores indicate better self-care. A
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score of ≥70 on each of the SCHFI scales is considered adequate.(24) Psychometric testing on the
Italian heart failure population showed that the Italian version of the SCHFI is a valid and reliable
tool to measure self-care maintenance and management.(26) Confirmatory factor analysis showed a
comparative fit index of 0.92 and a root mean square error of approximation of 0.05 for the selfcare maintenance scale; a comparative fit index of 0.95, and a root mean square error of
approximation of 0.07 for the self-care management scale. Reliability of the two scales, estimated
with the factor score determinacy, ranged between 0.78 and 0.90. (26)
Hospitalization
Hospitalization was measured as the number of admissions to an acute care facility due to
heart failure in the last year. These data were collected from patients’ medical records by research
assistants using an investigator-developed survey instrument.
Quality of life
Quality of life was measured with the Minnesota Living with Heart Failure Questionnaire
(MLHFQ), a 21-item instrument measuring the physical and emotional limitations experienced by
patients as attributed to their heart failure.(29) Each MLHFQ item uses a 6-point Likert response
format. The physical dimension score ranges from 0 to 40, the emotional dimension score ranges
from 0 to 25. Higher scores indicate worse quality of life. In order to make the interpretation of the
two MLHFQ dimensions comparable, the physical and emotional dimension scores were
standardized to 0 – 100 and reversed with higher scores indicating better quality of life. The
MLHFQ is widely used in Italian studies (30, 31) and its validity and reliability has been
established (32, 33). Reliability of the MLHFQ in this study resulted with a Cronbach’s alpha of
0.89 for the physical dimension, 0.86 for the emotional dimension and 0.92 for the whole
instrument.
Model Development
Based on our earlier studies (6, 17) and an extensive review of the literature conducted by
members of our group (34) we constructed a model a priori to test. The model represented the
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known relationships between the variables of interest – comorbidity, self-efficacy, self-care,
hospitalization and quality of life. Heart failure experts were consulted to confirm structural
validity before model testing (Figure 1).
Data Analysis
Data analysis was performed using SPSS 18.0 and MPlus 7.1. Descriptive statistics (mean,
SD, and frequencies) were used to describe the sociodemographic and clinical characteristics of the
sample (e.g., gender, ejection fraction). Pearson’s r was used to analyze the correlation between
comorbidity, self-efficacy, self-care, and outcomes (hospitalization and quality of life). Then data
were analyzed with a structural equation model (SEM). A multiplicative term (comorbidity and
self-efficacy) was created to examine the interaction effect. In order to reduce multicollinearity,
comorbidity and self-efficacy were centered by subtracting the corresponding mean from the score
of each variable.(35) Age and gender were covariates in the analysis. The following model fit
indices were considered: omnibus fit indices such as the chi square (χ2) and incremental fit indices
such as the Comparative Fit Index (CFI), the Root Mean Square Error of Approximation (RMSEA),
and the Weighted Root Mean Square Residual (WRMR). The following cut-off points were
considered acceptable fit indices: CFI > 0.95 ; RMSEA <.05 ; WRMR < 1.0.(36, 37)
To better interpret the significant interactions between self-efficacy and comorbidity on selfcare maintenance and management, post-hoc simple slopes analysis and graphical representation
were examined.(38) Specifically, we plotted the significant interaction effects for five levels of
comorbidity, defining the very low level as two standard deviations below the mean; the low level
as one standard deviation below the mean; the high level as plus one standard deviation above the
mean; and the very high level as two standard deviation above the mean. This method permits
plotting the relationship between self-efficacy and self-care behaviors (self-care maintenance and
self-care management) for each level of comorbidity and testing whether each slope is significantly
different from zero.
Results
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Sample
Table 1 presents the sociodemographic, family and clinical characteristics of the total
sample. The sample (n=628) was predominantly older (mean age = 72.98, SD = 11.34), male
(57.6%) and married (54.9%). Patients had lived with heart failure more than 4 years on average
and 75% of the sample was functionally compromised (NYHA classes II and III).
Descriptive statistics (Table 2)
Most (75.6%) had at least one other comorbid condition in addition to heart failure (CCI =
2.98; SD = 1.1). The most commonly reported comorbidities were atrial fibrillation (44.5%), prior
coronary events (40%), COPD (38%) and diabetes (36%). The mean scores of self-efficacy was
53.93 (SD = 20.55). Mean self-care maintenance and management were 54.99 (SD = 15.70) and
53.18 (SD = 20.01) respectively. Based on the cut-off of > 70, only about the 20% of the sample
performed adequate self-care. Most (73%) of the sample had been hospitalized due to heart failure
in the prior year. The mean length of hospital stay was 12.62 (SD = 8.75) days. Physical and
emotional quality of life were differentially affected by heart failure. Emotional quality of life
scores were almost half of the physical quality of life scores (24 and 41.5 respectively using the
reversed and standardized score).
Bivariate relationships with outcome variables
Table 3 shows the bivariate relationships between comorbidity, self-efficacy, self-care and
outcomes. Hospitalizations were more frequent in patients with more comorbid conditions, lower
self-care maintenance and worse physical and emotional quality of life. Better physical quality of
life was associated with fewer comorbid conditions, better self-efficacy and better self-care
maintenance. Better emotional quality of life was associated with fewer comorbid conditions and
better self-care maintenance.
Research Questions
Research Question 1): The original model (Figure 1), when tested, fit the data poorly: χ2(10)
= 82.64, p < .001; CFI =.89; RMSEA = .110 (CI=.089 - .132), p < .01; WRMR = 1.336.
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Modification indices showed a significant direct effect of comorbidity on physical quality of life
(higher comorbidity predicted lower physical quality of life) and hospitalization (higher
comorbidity predicted more frequent hospitalizations) and a correlation between physical quality of
life and hospitalization (higher physical quality of life was associated with fewer hospitalizations).
These three modifications were supported by prior research.(39-41) The revised model with the
three new parameters provided an excellent fit to the data: χ2(9) = 13.63, p = .14; CFI =.99;
RMSEA = .029 (CI=.000 - .059), p = .86; WRMR = .496. This model predicted 13% of the
variance in hospitalizations, 9% of the variance in physical quality of life, and 5% of the variance in
emotional quality of life.
As shown in Figure 2 higher levels of comorbidity were associated with lower levels of selfcare management. Higher levels of self-efficacy were associated with higher levels of self-care
maintenance and self-care management. Higher self-care maintenance was associated with higher
self-care management.
Research Question 2): In the moderation analysis, comorbidity moderated only the relation
between self-efficacy and self-care maintenance. Higher self-care maintenance was associated with
higher physical and emotional quality of life and fewer hospitalizations; higher self-care
management was associated with lower emotional quality of life.
Post-hoc simple slopes analysis (Figure 3) showed significant differences among the slope
coefficients (pdiff <.05). In patients with lower comorbidity the strength of the relationship between
self-efficacy and self-care maintenance was stronger than in patients with higher comorbidity. In
fact, as the level of comorbidity increased the relationship between self-efficacy and self-care
maintenance decreased (from 0.55 in patients with the lowest comorbidity to 0.24 in patients with
highest comorbidity). So, the strength of the relationship between self-efficacy and self-care was a
function of comorbidity.
Discussion
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The specific aim of this study was to test an explanatory model of known predictors of
hospitalization and quality of life by identifying the contribution of comorbidity to heart failure selfcare and then testing comorbidity as a moderator of the relationship between self-efficacy and heart
failure self-care behaviors. To our knowledge this is the first study describing the manner in which
comorbidity, self-efficacy, and heart failure self-care interact to influence hospitalization and
quality of life. In answer to our first question, comorbidity contributes significantly (directly and
indirectly) to self-care behaviors and outcomes. In answer to our second question, the moderation
hypothesis was supported in part when it was found that comorbidity moderates the relationship
between self-efficacy and self-care maintenance but not self-care management. We also
demonstrated that self-care maintenance was associated positively with both physical and emotional
quality of life while negatively associated (directly and indirectly) with hospitalization.
The findings in this study support theoretical predictions (8) and prior work that selfefficacy is important in the self-care process. Self-efficacy has both a positive and a negative
impact. That is, high self-efficacy is associated with better quality of life while low self-efficacy is a
barrier to self-care. Previously, in a US sample we found that differentiating among symptoms is
extremely difficult for patients.(17) Patients rarely integrate self-care instructions and ultimately
prioritize their self-care based on the perceived threat and their experience with the particular
condition. This finding suggested that the prioritization process may be influenced by the degree of
self-efficacy felt in relation to a particular chronic condition.(17) Qualitatively, in a subsequent
mixed methods study, we found that self-efficacy shaped how patients with comorbidity made selfcare maintenance and management decisions, particularly in maintaining dietary restrictions and
making dietary choices, two key elements in treatment adherence.(6) Quantitatively, in that same
study, there were statistically significant differences in self-care maintenance and management
scores in groups with low vs. moderate or high comorbidity levels; with those with greater
comorbidity scoring lower in self-care. In a moderation analysis comorbidity moderated the
relationship between self-efficacy and self-care maintenance in the group with a moderate number
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(2-3) of chronic illnesses but not in the low comorbidity group (0-1 chronic illness). However, no
moderator effect was found between self-efficacy and self-care management, which is consistent
with the results reported here.
The findings of this study are supported by a recent German study where self-efficacy was
identified as a determinant of heart failure self-care adherence.(9) Our study in an Italian sample
adds to their results by recognizing that comorbidity complicates the day to day decisions about not
just adherence but also symptom monitoring, both subdomains of self-care maintenance. In an
earlier Canadian study significant associations were found between self-efficacy and self-care
maintenance as well number of comorbidities and quality of life in bivariate analysis but in
multivariate analysis this significance disappeared.(42) This result may have been a function of
ignoring comorbidity as a moderator of self-efficacy. But taken together, the three earlier studies
and our study, conducted in four different countries (two European, two North American), suggest
that self-efficacy is universally important. Further testing of this hypothesis in different geographic
areas is suggested.
However, focusing on increasing self-efficacy is not sufficient as the number of diseases
increases or as a disease progresses. We found in the slope analysis that as the level of comorbidity
increased the relationship between self-efficacy and self-care maintenance decreased, even though it
remained statistically significant. Therefore, while there is a pressing need to develop interventions
that increase patient self-efficacy early in the diagnosis; as the relationship between self-efficacy
and self-care maintenance weakens this may no longer be sufficient to maintain the patient safely in
a community setting. One potential option to mitigate the impact of comorbidity on the patient’s
self-care is to increase caregiver education and support as the patients’ number of diseases increases
or progresses. Nonetheless, we also need to understand the limitations of our current interventions
and education protocols. In the presence of greater comorbidity, focusing on improving either
patient or caregiver self-efficacy may be insufficient to assure improved outcomes such as patient
quality of life, event free survival, or costs. Heart failure patients and families may need earlier
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referral to supportive or palliative care to manage the patient’s comorbidity at home. Further study
is needed on the effect of earlier referral before this can rise to the level of a recommendation. In the
interim, clinicians would do well to consider the comorbidity burden of their patients and assess the
impact on informal caregivers.
Limitations
This study involved a secondary analysis of existing cross sectional data from one particular
country. Furthermore, we selected only symptomatic patients. This resulted in a sicker population
who may have been further along in the trajectory of heart failure than commonly seen. However,
given the common exclusion of this sicker population from large clinical trials, we feel that their
inclusion is a strength of the study. Other strengths include the robust sample size (n=628) and
testing of a model developed from the literature and our previous work.(6) The current findings, in a
unique population, support our earlier study.
Implication for Research
First, there is a need for rigorous, prospective, longitudinal, trials designed to specifically
tease out the nuances in the relationships between comorbidity and heart failure self-care. To date
all of the work has been done with existing cross sectional datasets. Second, there is the need to
account for moderators in explaining the mechanism or meaningfulness of the relationships between
variables. If heart failure researchers are not measuring comorbidity and accounting for it in
analytic plans then we may be mis-specifying relationships among other variables and missing
accurate explanations for the occurrence of certain relationships. Third, we have presented an
explanatory model of the interaction of known predictors of hospitalization and quality of life with
empirically verified parameters. However, while this model explained only 13% of the variance in
hospitalization we achieved our aim which was to identify the contribution of comorbidity and its
role as a moderator in self-care. We recommend that future studies include other variables and then
repeat testing of the model to build the science. Fourth, we recommend that future interventional
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studies use our model as means to identify and target heart failure patients at higher risk for
decreased quality of life or increased hospitalizations.
Conclusion
This study presented an explanatory model of variables known to be associated with
hospitalization and quality of life in heart failure and identified the contribution of comorbidity. It
was found that comorbidity differentially moderated the relationship between self-care self-efficacy
and self-care maintenance but did not moderate the relationship with self-care management. Given
what is known about comorbidity’s association with longer lengths of hospital stay, more hospital
stays per year, and higher overall costs of care; this model provides greater understanding of this
relationship.
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What is already known about the topic?





Comorbidity is associated with longer lengths of hospital stay, more hospital stays per
year, and higher overall costs of care
Understanding the interplay of known antecedents of adequate heart failure self-care is
necessary to begin to address rising hospitalization rates associated with comorbidity.
In earlier work we established that there is interaction between comorbidity, selfefficacy and heart failure self-care

What this paper adds.




An explanatory model of the interaction of known predictors of hospitalization and
quality of life with empirically verified parameters
Comorbidity moderates the relationship between self-efficacy and self-care
maintenance but not self-care management
As the level of comorbidity increased the relationship between self-efficacy and selfcare maintenance decreased
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Figure 1. The Theoretical Model guiding the study
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Figure 2. The Final Model
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Note. The above model explained 9% of the variance in Physical Quality of life; 5% of the variance in
Emotional Quality of life; and 13% of the variance in Hospitalization
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Figure 3. Moderation analysis
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Note. This figure illustrates the relationship between Self-care Self-efficacy and Self-care Maintenance
for different levels of comorbidity (very low, low, medium, high and very high comorbidity). For each
effect the slope coefficient is provided
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Table 1 Socio-Demographic, Family and Clinical Characteristics of Patients (N=628)
Variables
Age

M(SD)

N(%)

72.98 (11.34)

Gender
Male

362 (57.6)

Female

266 (42.4)

Education
Elementary School

326 (51.9)

Middle School

152 (24.2)

Professional School

43 (6.9)

High School

74 (11.7)

University Degree

33 (5.3)

Marital Status
Married

245 (54.9)

Widowed

198 (31.4)

Single

49 (7.8)

Divorced

37 (5.9)

Job
Employed

542 (86.3)

Unemployed/Retired

86 (13.7)

Family income per month
(Euros, n = 606)
0 – 1000

209 (34.5)

1001 – 2000

206 (50.5)

>2000

91 (15.0)

Illness duration (months)

55.95 (45.6)

Ejection Fraction

43.13 (11.5)

NYHA class
I

56 (8.9)

II

231 (36.8)

III

263 (41.8)

IV

78 (12.4)
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Table 2. Comorbidities, HF Self-care Behaviors and Outcomes (N=628)
Variables
CCI score
Other Comorbidities
Atrial fibrillation
Prior Acute Coronary Syndrome
COPD
Diabetes
Anemia
Peripheral vascular disease
Renal disease
Sleep apnea
Peptic ulcer
Hemiplegia/Stroke
Liver disease
Cancer
Connective tissue disease
Leukemia
Lymphoma
Self-care behaviors
Self-care maintenance
Self-care management
Self-care confidence (selfefficacy)
MLHFQ
Physical dimension
Emotional dimension

M (SD)

N(%)

2.98 (1.1)
279 (44.5)
251 (40.0)
238 (38.0)
226 (36.0)
141 (23.7)
119 (19.0)
119 (19.0)
107 (17.1)
75 (11.9)
59 (9.4)
39 (6.2)
40 (6.4)
19 (3.0)
4 (0.6)
2 (0.3)
54.99 (15.70)
53.18 (20.01)
53.93 (20.55)

41.5 (21.2)
24.0 (12.0)

Hospitalization in last year
Never hospitalized
232 (26.9)
Hospitalized once
252 (40.1)
Hospitalized twice
98 (15.6)
Hospitalized > 3 times
46 (7.3)
Note. CCI = Charlson Comorbidity Index; COPD = Chronic Obstructive Pulmonary Disease;
MLHFQ = Minnesota Living with Heart Failure Questionnaire; MLHFQ scores have been reversed
(higher score = better QOL) and standardized on 0 – 100 range; patients could have more than one
illness.
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Table 3. Bivariate relationships among Comorbidity, Self-efficacy, Self-care and Outcomes
1
2
3
4
5
6
1. CCI
1
2. Self-care self-efficacy
-.071
1
3. Self-care maintenance
-.066
.512**
1
4. Self-care management
-.114**
.579**
.406**
1
5. MLHFQ-P
-.257**
.088*
.107**
.074
1
6. MLHFQ-E
-.163**
.024
.112**
-.039
.638**
1
7. Number of hospitalizations
.211**
-.157** -.177**
-.066
-.180** -.110**
Note. CCI = Charlson Comorbidity Index; MLHFQ-P = Minnesota Living with Heart Failure
Questionnaire Physical Dimension; MLHFQ-E = Minnesota Living with Heart Failure Questionnaire
Emotional Dimension. The scores of the MLHFQ-P and MLHFQ-E have been reversed with higher
scores meaning better quality of life; * = p < 0.05; ** = p < 0.01.
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